Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indranil Bhattacharya

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Biochimica Et Biophysica Acta|September 19, 2013
Malfunctioning of adipocytes in obesity is linked to quantitative surfaceome changesHansjoerg Moest, Andreas P Frei, Indranil Bhattacharya, et al.
European Journal of Clinical Pharmacology|December 7, 2011
Repeat-dose sirolimus pharmacokinetics and pharmacodynamics in patients with hepatic allograftsJürg Reichen, Felix Stickel, Indranil Bhattacharya, et al.
Clinical and Translational Science|August 22, 2020
A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 1 - Model FrameworkKatharine V Rogers, Steven W Martin, Indranil Bhattacharya, et al.
Indian Journal of Pathology & Microbiology|September 28, 2006
Disseminated histoplasmosis mimicking laryngeal carcinoma from central India--a case reportA M Phatak, Indranil Bhattacharya, Vaibhav Misra, et al.
Clinical Therapeutics|April 27, 2016
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic LupusStanley Cohen, Megan Clowse, Patricia Pardo, et al.
Biochemical and Biophysical Research Communications|April 18, 2015
Hypoxia potentiates tumor necrosis factor-α induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in white and brown adipocytesIndranil Bhattacharya, Ana Pérez Domínguez, Katja Drägert, et al.
Clinical and Translational Science|August 22, 2020
A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 2 - Application to Current Therapies in Crohn's DiseaseKatharine V Rogers, Steven W Martin, Indranil Bhattacharya, et al.
BMC Primary Care|April 22, 2024
Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetesRachel S Newson, Erik Spaepen, Birong Liao, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Comparative Sirolimus Pharmacokinetics After Single-Dose Administration of Two Prototype 0.5-mg Tablets in Healthy VolunteersJoan M Korth-Bradley, Indranil Bhattacharya, Kyle Matschke, et al.
International Journal of Molecular Sciences|October 23, 2021
Effect of N-Vinyl-2-Pyrrolidone (NVP), a Bromodomain-Binding Small Chemical, on Osteoblast and Osteoclast Differentiation and Its Potential Application for Bone RegenerationViviane A Klemmer, Nupur Khera, Barbara M Siegenthaler, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta|September 19, 2013
Malfunctioning of adipocytes in obesity is linked to quantitative surfaceome changesHansjoerg Moest, Andreas P Frei, Indranil Bhattacharya, et al.
European Journal of Clinical Pharmacology|December 7, 2011
Repeat-dose sirolimus pharmacokinetics and pharmacodynamics in patients with hepatic allograftsJürg Reichen, Felix Stickel, Indranil Bhattacharya, et al.
Clinical and Translational Science|August 22, 2020
A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 1 - Model FrameworkKatharine V Rogers, Steven W Martin, Indranil Bhattacharya, et al.
Indian Journal of Pathology & Microbiology|September 28, 2006
Disseminated histoplasmosis mimicking laryngeal carcinoma from central India--a case reportA M Phatak, Indranil Bhattacharya, Vaibhav Misra, et al.
Clinical Therapeutics|April 27, 2016
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic LupusStanley Cohen, Megan Clowse, Patricia Pardo, et al.
Biochemical and Biophysical Research Communications|April 18, 2015
Hypoxia potentiates tumor necrosis factor-α induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in white and brown adipocytesIndranil Bhattacharya, Ana Pérez Domínguez, Katja Drägert, et al.
Clinical and Translational Science|August 22, 2020
A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 2 - Application to Current Therapies in Crohn's DiseaseKatharine V Rogers, Steven W Martin, Indranil Bhattacharya, et al.
BMC Primary Care|April 22, 2024
Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetesRachel S Newson, Erik Spaepen, Birong Liao, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Comparative Sirolimus Pharmacokinetics After Single-Dose Administration of Two Prototype 0.5-mg Tablets in Healthy VolunteersJoan M Korth-Bradley, Indranil Bhattacharya, Kyle Matschke, et al.
International Journal of Molecular Sciences|October 23, 2021
Effect of N-Vinyl-2-Pyrrolidone (NVP), a Bromodomain-Binding Small Chemical, on Osteoblast and Osteoclast Differentiation and Its Potential Application for Bone RegenerationViviane A Klemmer, Nupur Khera, Barbara M Siegenthaler, et al.
Pageof 7